These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 40264)

  • 21. Screening of dependence liability of drugs using rats.
    Hosoya E
    Pharmacol Ther B; 1979; 5(1-3):515-7. PubMed ID: 573907
    [No Abstract]   [Full Text] [Related]  

  • 22. [Physical dependence of dihydroetorphine in mice and monkeys (author's transl)].
    Huang M; Qin BY
    Zhongguo Yao Li Xue Bao; 1982 Jun; 3(2):81-4. PubMed ID: 6214153
    [No Abstract]   [Full Text] [Related]  

  • 23. A comparison of clonidine with morphine for antinociceptive and antiwithdrawal actions.
    Fielding S; Wilker J; Hynes M; Szewczak M; Novick WJ; Lal H
    J Pharmacol Exp Ther; 1978 Dec; 207(3):899-905. PubMed ID: 569695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dependence studies of new compounds in the rhesus monkey, rat, and mouse (1983).
    Aceto MD; Harris LS; May EL
    NIDA Res Monogr; 1984 Mar; 49():368-420. PubMed ID: 6434986
    [No Abstract]   [Full Text] [Related]  

  • 25. Activation of serotonin 5-HT(2C) receptor suppresses behavioral sensitization and naloxone-precipitated withdrawal symptoms in morphine-dependent mice.
    Zhang G; Wu X; Zhang YM; Liu H; Jiang Q; Pang G; Tao X; Dong L; Stackman RW
    Neuropharmacology; 2016 Feb; 101():246-54. PubMed ID: 26432939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduction of opioid withdrawal and potentiation of acute opioid analgesia by systemic AV411 (ibudilast).
    Hutchinson MR; Lewis SS; Coats BD; Skyba DA; Crysdale NY; Berkelhammer DL; Brzeski A; Northcutt A; Vietz CM; Judd CM; Maier SF; Watkins LR; Johnson KW
    Brain Behav Immun; 2009 Feb; 23(2):240-50. PubMed ID: 18938237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pioglitazone attenuates the opioid withdrawal and vulnerability to relapse to heroin seeking in rodents.
    de Guglielmo G; Kallupi M; Scuppa G; Demopulos G; Gaitanaris G; Ciccocioppo R
    Psychopharmacology (Berl); 2017 Jan; 234(2):223-234. PubMed ID: 27714428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of the effectiveness of drugs to substitute for morphine in the opiate-dependent rhesus monkey [proceedings].
    Crossland NJ; Turnbull MJ
    Br J Pharmacol; 1977 Nov; 61(3):489P-490P. PubMed ID: 412543
    [No Abstract]   [Full Text] [Related]  

  • 29. Spironolactone decreases the somatic signs of opiate withdrawal by blocking the mineralocorticoid receptors (MR).
    Navarro-Zaragoza J; Laorden ML; Milanés MV
    Toxicology; 2014 Dec; 326():36-43. PubMed ID: 25308750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acetyl-L-carnitine in the management of pain during methadone withdrawal syndrome.
    Janiri L; Martinotti G; Tonioni F; Ghelardini C; Nicolai R; Galeotti N; Mosconi L; Calvani M; Bartolini A; Iannoni E
    Clin Neuropharmacol; 2009; 32(1):35-40. PubMed ID: 18978503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of 18-methoxycoronaridine on acute signs of morphine withdrawal in rats.
    Rho B; Glick SD
    Neuroreport; 1998 May; 9(7):1283-5. PubMed ID: 9631413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A case of physical and psychological dependence on butorphanol.
    Harshe DG; Mate OS; Cholera RM; Kale S
    J Opioid Manag; 2015; 11(2):112-3. PubMed ID: 26035913
    [No Abstract]   [Full Text] [Related]  

  • 33. Psychological approaches to opiate dependence and self-administration by laboratory animals.
    Schuster CR
    Fed Proc; 1970; 29(1):2-5. PubMed ID: 4983813
    [No Abstract]   [Full Text] [Related]  

  • 34. Assessment of the abuse potential of acetorphan, an enkephalinase inhibitor.
    Knisely JS; Beardsley PM; Aceto MD; Balster RL; Harris LS
    Drug Alcohol Depend; 1989 Apr; 23(2):143-51. PubMed ID: 2702924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
    Rehni AK; Bhateja P; Singh TG; Singh N
    Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of propranolol on antinociceptive and withdrawal characteristics of morphine.
    Chipkin RE; Dewey WL; Harris LS; Lowenthal W
    Pharmacol Biochem Behav; 1975; 3(5):843-7. PubMed ID: 1800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment with tramadol can give rise to dependence and abuse].
    Näslund S; Dahlqvist R
    Lakartidningen; 2003 Feb; 100(9):712-4. PubMed ID: 12674559
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clonidine and naloxone-induced opiate withdrawal: a comparison between clonidine and morphine in man.
    Fantozzi R; Luciani G; Masini E; Blandina P; Mannaioni P
    Subst Alcohol Actions Misuse; 1980; 1(4):369-73. PubMed ID: 7302789
    [No Abstract]   [Full Text] [Related]  

  • 39. Should opioid abusers be discharged from opioid-analgesic therapy?
    Compton P
    Pain Med; 2008; 9(4):383-90. PubMed ID: 18489627
    [No Abstract]   [Full Text] [Related]  

  • 40. Adolescent nicotine challenge promotes the future vulnerability to opioid addiction: Involvement of lateral paragigantocellularis neurons.
    Torabi M; Azizi H; Ahmadi-Soleimani SM; Rezayof A
    Life Sci; 2019 Oct; 234():116784. PubMed ID: 31445026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.